Project Name ：Olanzapine - Fluoxetine Capsules
Registration Classification ：3.2
Formulations and specifications ：
Indications：Treatment for the acute phase : Depression Bipolar I disorder adult onset ; refractory depression ( no effect after using two separate trials of different antidepressants with sufficient dose and duration ) .
Original Research Company：Eli Lilly
Progress：Beijing Bureau has reported , in the form of review
